20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
As we grow accustomed to the new normal of face coverings during a haircut, social distancing on wal...
Read More >
On May 18, 2020, the Baker-Polito Administration revealed its four-phased approach to reopening the ...
Read More >
The majority of middle-market M&A has followed a similar structure for quite some time: while ensuri...
Read More >
Our autumn round-up of articles written by colleagues highlights a wide range of issues affecting bu...
Read More >
The ERISA Industry Committee (ERIC), Fidelity and McDermott invite you to join your peers and collea...
Read More >
The U.S. Department of Labor is still working to finalize the withdrawal of the 80/20 rule, which ha...
Read More >